Tuesday, October 21, 2014

Precision Marketing Partners Helping Lifestyle Medical Center Spread the Word About Preventative Health and Well-Being Programs

RALEIGH & DURHAM, N.C. -- Precision Marketing Partners, a full-service marketing firm for the medical and healthcare industry, is pleased to announce it has been selected by Lifestyle Medical Center to provide inbound marketing, branding, creative design and strategic planning services for the Durham-based group and its health and well-being programs. Precision Marketing Partners will be redeveloping the LifestyleMedicalCenters.com website as part of a full marketing plan the firm is building, including social media, multimedia, and other proven-effective marketing tools to help attract new patients.

Monday, October 20, 2014

Kids Games Device, Osmo, Secures $12M in Series A Funding Led by Accel Partners

PALO ALTO, CALIF. --— Today, Osmo, the hardware games device for kids that connects to any iPad, announced it has closed $12 million in Series A Round funding led by investor Accel Partners. Other investors participating in the funding round include Upfront Ventures and K9 Ventures. As part of the investment, Accel Partners' Rich Wong will join the company’s board of directors.

Friday, October 17, 2014

Action-Packed Murder Mystery “OBX” Joins KDP Select Program for Amazon Kindle

Exclusive Availability Follows Release of Two All-New Kindles

OUTER BANKS, N.C. -- The action-packed murder mystery “OBX” is now available exclusively for the Amazon Kindle, including the newly released 7th generation of Kindle: Kindle Voyage, Amazon’s most advanced e-reader ever, and the new $79 Kindle, with a 20 percent faster processor, twice the storage and new touch interface. OBX follows North Carolina State Bureau of Investigation agent and troubled mother-of-three Michael Francis as she battles personal demons and real-life danger to solve a brutal politically charged murder case as a hurricane bears down on the seaside vacation mecca of the Outer Banks.

Thursday, October 16, 2014

Ephesoft Makes “Smart” Move With Introduction of SnapDoc Mobile Smart Capture™

LAGUNA HILLS, CALIF. -- Ephesoft Inc., creators of the industry-leading Smart Capture™ advanced document capture platform has unveiled the latest convenience in document capture solutions. SnapDoc by Ephesoft literally puts the power of document capture in your hand, allowing you to browse or capture documents directly from your mobile device. From there, you can remotely send documents directly to a batch class, perform data extraction, and even generate XML and PDF files on the fly.

Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer

TEL AVIV, ISRAEL -- Compugen Ltd. (NASDAQ: CGEN) disclosed today that it has achieved a second milestone in its cancer immunotherapy collaboration it entered last year with Bayer HealthCare (Bayer). The collaboration provides for the research, development, and commercialization of antibody-based cancer therapeutics against two novel Compugen-discovered immune checkpoint regulators. The milestone being announced today relates to the second preclinical milestone for one of the checkpoint protein candidates. The achievement of the initial milestone for this candidate was announced in July of this year.

Brad Hayden, Robotic Skies President & CEO Moderates NBAA UAS Panel

ALBUQUERQUE, N.M. -- UAS are the topic of a National Business Aviation Association (NBAA) panel discussion, Unmanned Aircraft Systems: Opportunities for Business Aviation to be held on Wednesday, October 22, 2014, at 1:30 p.m. in the Innovation Zone (Booth #288) of the Orange County Convention Center in Orlando. Moderated by Robotic Skies President & CEO Brad Hayden, this forum represents the first time UAS have been a focus at NBAA. "Stop saying that UAS are coming - they're already here!" says Hayden. "When the FAA regulations are finalized, the commercial use of UAS will have the power to impact every flight department worldwide so, through this panel, NBAA is providing up-to-the-minute information of their potential uses for its members."

TxCell to present on T Cellular Therapy for Autoimmune Diseases at the 7th National Bio-Therapy Conference 2014, China

VALBONNE, FRANCE -- TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.